Yoav Lurie

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

Stephen A. Harrison, Vincent Wai‐Sun Wong, Takeshi Okanoue et al. · Journal of Hepatology · 2020 · 438 citations

Fibrosis, Hepatology, Liver Physiology +9

A Double-Blind Randomized Placebo-Controlled Trial of Orlistat for the Treatment of Nonalcoholic Fatty Liver Disease

Shira Zelber‐Sagi, Ada Kessler, Eli Brazowsky et al. · Clinical Gastroenterology and Hepatology · 2006 · 314 citations · Full text

Obesity, Metabolic Syndrome, Hepatology +7

Lamotrigine reduces painful diabetic neuropathy

Elon Eisenberg, Yoav Lurie, Clara Braker et al. · Neurology · 2001 · 299 citations

The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease

Rifaat Safadi, Fred M. Konikoff, Mahmud Mahamid et al. · Clinical Gastroenterology and Hepatology · 2014 · 270 citations · Full text